William A. Gray, MD, FSCAI

System Chief of Cardiovascular Services, Main Line Health/President, Lankenau Heart Institute
Main Line Health
Wynnewood, Pennsylvania, United States

Dr. William Gray is an interventional cardiologist certified by the American Board of Internal Medicine, with subspecialty certification in internal medicine, cardiology, and interventional cardiology. He is also certified in vascular and endovascular medicine by the American Board of Vascular Medicine.
Dr. Gray specializes in the diagnosis and treatment of cardiac/structural and peripheral arterial disease, with special interests in novel nonsurgical modalities for stroke prevention (carotid stenting and left atrial appendage occlusion devices).
Dr. Gray earned his medical degree at Temple University School of Medicine (now known as Lewis Katz School of Medicine), Philadelphia, PA. He completed an internal medicine residency and chief residency at Brown University-affiliated Rhode Island Hospital, Providence, where he also completed a clinical and research cardiology fellowship.

Presentation(s):

• Power Break Symposium: Eluvia DES in Femoropopliteal Disease: A First Look at 5-Year Outcomes from the IMPERIAL RCT (Non-CME) - Sponsored by Boston Scientific Corporation

  Sunday, February 26, 2023
  1:00 PM – 2:00 PM ET

  Disclosure(s): Alucent: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Contracted Research (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Contracted Research (Ongoing); efemoral: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Contracted Research (Ongoing); phillips: Consultant (Ongoing), Contracted Research (Ongoing); shockwave: Consultant (Ongoing), Contracted Research (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)

• Tricuspid Annuloplasty

  Sunday, February 26, 2023
  3:47 PM – 3:55 PM ET

  Disclosure(s): Alucent: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Contracted Research (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Contracted Research (Ongoing); efemoral: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Contracted Research (Ongoing); phillips: Consultant (Ongoing), Contracted Research (Ongoing); shockwave: Consultant (Ongoing), Contracted Research (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)

• Conformal Self-Adaptable LAA Closure Device: Initial Clinical Experience

  Sunday, February 26, 2023
  4:47 PM – 4:55 PM ET

  Disclosure(s): Alucent: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Contracted Research (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Contracted Research (Ongoing); efemoral: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Contracted Research (Ongoing); phillips: Consultant (Ongoing), Contracted Research (Ongoing); shockwave: Consultant (Ongoing), Contracted Research (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)

• Panel Discussion: What Does the Future Hold for LAA Closure?

  Sunday, February 26, 2023
  5:11 PM – 5:30 PM ET

  Disclosure(s): Alucent: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Contracted Research (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Contracted Research (Ongoing); efemoral: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Contracted Research (Ongoing); phillips: Consultant (Ongoing), Contracted Research (Ongoing); shockwave: Consultant (Ongoing), Contracted Research (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)

• Five-Year Results from the IMPERIAL Randomized Study of Eluvia and Zilver PTX Drug-Eluting Stents and the Long Lesion Substudy for Femoropopliteal Artery Disease

  Sunday, February 26, 2023
  9:15 AM – 9:25 AM ET

  Disclosure(s): Alucent: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Contracted Research (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Contracted Research (Ongoing); efemoral: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Contracted Research (Ongoing); phillips: Consultant (Ongoing), Contracted Research (Ongoing); shockwave: Consultant (Ongoing), Contracted Research (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)

• Day 2: Vessel prep, Balloons and Stents

  Monday, February 27, 2023
  6:15 AM – 7:50 AM ET

  Disclosure(s): Alucent: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Contracted Research (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Contracted Research (Ongoing); efemoral: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Contracted Research (Ongoing); phillips: Consultant (Ongoing), Contracted Research (Ongoing); shockwave: Consultant (Ongoing), Contracted Research (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)

• Panel Discussion

  Monday, February 27, 2023
  7:40 AM – 7:55 AM ET

  Disclosure(s): Alucent: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Contracted Research (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Contracted Research (Ongoing); efemoral: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Contracted Research (Ongoing); phillips: Consultant (Ongoing), Contracted Research (Ongoing); shockwave: Consultant (Ongoing), Contracted Research (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)

• Panel Discussion | Questions and Answers

  Monday, February 27, 2023
  11:42 AM – 12:00 PM ET

  Disclosure(s): Alucent: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Contracted Research (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Contracted Research (Ongoing); efemoral: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Contracted Research (Ongoing); phillips: Consultant (Ongoing), Contracted Research (Ongoing); shockwave: Consultant (Ongoing), Contracted Research (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)

• SFA: DRUG-COATED BALLOON, DRUG-ELUTING STENTS AND STENTS GRAFTS

  Monday, February 27, 2023
  3:30 PM – 4:42 PM ET

  Disclosure(s): Alucent: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Contracted Research (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Contracted Research (Ongoing); efemoral: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Contracted Research (Ongoing); phillips: Consultant (Ongoing), Contracted Research (Ongoing); shockwave: Consultant (Ongoing), Contracted Research (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)

• Panel Discussion: Optimal Device Selection for CLI with Durable Patency

  Monday, February 27, 2023
  4:26 PM – 4:42 PM ET

  Disclosure(s): Alucent: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Contracted Research (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Contracted Research (Ongoing); efemoral: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Contracted Research (Ongoing); phillips: Consultant (Ongoing), Contracted Research (Ongoing); shockwave: Consultant (Ongoing), Contracted Research (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)

• Panel Discussion: All Things CLI

  Monday, February 27, 2023
  5:06 PM – 5:25 PM ET

  Disclosure(s): Alucent: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Contracted Research (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Contracted Research (Ongoing); efemoral: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Contracted Research (Ongoing); phillips: Consultant (Ongoing), Contracted Research (Ongoing); shockwave: Consultant (Ongoing), Contracted Research (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)